Amylyx Pharmaceuticals Stock Forecast

Stock Price Forecast

According to 12 analysts polled by S&P Global, Amylyx Pharmaceuticals stock has a consensus rating of "Strong Buy" and an average price target of $42.36. The average 1-year stock price forecast is 24.22% higher than the current stock price, while the lowest is $20 (-41.35%) and the highest is $57 (+67.16%).

Price Target: $42.36 (+24.22%)

Analyst Consensus: Strong Buy

Price Target

Chart

Target	Low	Average	Median	High
Price	$20	$42.36	$42	$57
Change	-41.35%	+24.22%	+23.17%	+67.16%

Analyst Ratings

The average analyst rating for Amylyx Pharmaceuticals stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Chart

Rating	Mar '26	Apr '26	May '26	Jun '26	Jul '26	Aug '26
Strong Buy	11	11	11	11	10	11
Buy	0	0	0	0	0	0
Hold	1	1	1	1	1	1
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	12	12	12	12	11	12

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Seamus Fernandez Guggenheim	Guggenheim	Buy Reiterates $55 → $57	Buy	Reiterates	$55 → $57	+67.16%	Aug 27, 2026
Rami Katkhuda LifeSci Capital	LifeSci Capital	Buy Maintains $24 → $44	Buy	Maintains	$24 → $44	+29.03%	Aug 22, 2026
Joseph Thome TD Cowen	TD Cowen	Buy Maintains n/a	Buy	Maintains	n/a	n/a	Aug 19, 2026
Jason Gerberry Bank of America Securities	Bank of America Securities	Buy Reiterates $39	Buy	Reiterates	$39	+14.37%	Aug 19, 2026
Christopher Chen Robert W. Baird	Robert W. Baird	Buy Maintains $28 → $52	Buy	Maintains	$28 → $52	+52.49%	Aug 18, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

n/a

Revenue Next Year

28.23M

EPS This Year

-1.50

from -1.53

EPS Next Year

-1.15

from -1.50

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	285.00K	22.23M	380.79M	87.37M	-	-
Gross Profit	-43.76M	-74.21M	227.16M	-141.35M	-90.40M	-
Gross Margin	-15,352.63%	-333.84%	59.66%	-161.78%	-	-
Operating Income	-82.69M	-201.34M	38.80M	-255.68M	-153.29M	-182.11M
Net Income	-87.93M	-198.38M	49.27M	-301.74M	-144.74M	-175.82M
EPS	-	-	-	-	-1.53	-1.50
Free Cash Flow	-46.85M	-105.35M	38.36M	-134.74M	-66.99M	-160.20M
No. Analysts	-	-	-	-	-	11

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Chart

Revenue	2026	2027	2028
High	n/a
Avg	n/a
Low	n/a

Revenue Growth

Chart

Revenue Growth	2027	2028
High	-
Avg	-
Low	-

EPS Forecast

Chart

EPS	2026	2027	2028
High	-1.37
Avg	-1.50
Low	-1.60

EPS Growth

Chart

EPS Growth	2026	2027	2028
High	-
Avg	-
Low	-